surmount-1 tirzepatide weight loss results trial Analysis of Acquisition Costs and Reduction Outcomes in the United Kingdom: Insights from the Study GLP-1.Reviews on X: "The SURMOUNT-5

You have GLP-1 receptors in your: Digestive system: It slows down how quickly food leaves your stomach, which helps you feel full longer

Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available

The SmPC for Saxenda does not list gastroparesis as a recognised adverse effect

Other things to keep in mind: Tirzepatide should be avoided in patients with a history of medullary thyroid carcinoma (or MTC), as well as MEN2 [multiple endocrine neoplasia type 2], severe gastroparesis, or those who are pregnant